These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21792029)

  • 1. Effects of growth hormone therapy on bone mass, metabolic balance, and well-being in young adult survivors of childhood acute lymphoblastic leukemia.
    van den Heijkant S; Hoorweg-Nijman G; Huisman J; Drent M; van der Pal H; Kaspers GJ; Delemarre-van de Waal H
    J Pediatr Hematol Oncol; 2011 Aug; 33(6):e231-8. PubMed ID: 21792029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced bone mineral density in young adults following cure of acute lymphoblastic leukaemia in childhood.
    Brennan BM; Rahim A; Adams JA; Eden OB; Shalet SM
    Br J Cancer; 1999 Apr; 79(11-12):1859-63. PubMed ID: 10206305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia.
    van Beek RD; de Muinck Keizer-Schrama SM; Hakvoort-Cammel FG; van der Sluis IM; Krenning EP; Pieters R; van den Heuvel-Eibrink MM
    Pediatr Blood Cancer; 2006 Jan; 46(1):88-93. PubMed ID: 15926166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and -5 correlate with bone mineral density in growth hormone (GH)-deficient adults and increase with GH replacement therapy.
    Thorén M; Hilding A; Brismar T; Magnusson P; Degerblad M; Larsson L; Sääf M; Baylink DJ; Mohan S
    J Bone Miner Res; 1998 May; 13(5):891-9. PubMed ID: 9610754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study.
    Marinovic D; Dorgeret S; Lescoeur B; Alberti C; Noel M; Czernichow P; Sebag G; Vilmer E; Léger J
    Pediatrics; 2005 Jul; 116(1):e102-8. PubMed ID: 15995009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W; Briody J; Moore B; Lu PW; Cowell CT
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survivors of childhood acute lymphoblastic leukaemia, with radiation-induced GH deficiency, exhibit hyperleptinaemia and impaired insulin sensitivity, unaffected by 12 months of GH treatment.
    Bülow B; Link K; Ahrén B; Nilsson AS; Erfurth EM
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):683-91. PubMed ID: 15579181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone mineral density and serum bone turnover markers in survivors of childhood acute lymphoblastic leukemia: comparison of megadose methylprednisolone and conventional-dose prednisolone treatments.
    Alikasifoglu A; Yetgin S; Cetin M; Tuncer M; Gumruk F; Gurgey A; Yordam N
    Am J Hematol; 2005 Oct; 80(2):113-8. PubMed ID: 16184587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of idiopathic childhood-onset growth hormone deficiency (GHD) on bone mass in subjects without adult GHD.
    Lange M; Müller J; Svendsen OL; Kastrup KW; Juul A; Feldt-Rasmussen U
    Clin Endocrinol (Oxf); 2005 Jan; 62(1):18-23. PubMed ID: 15638865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The limited screening value of insulin-like growth factor-I as a marker for alterations in body composition in very long-term adult survivors of childhood cancer.
    Blijdorp K; van den Heuvel-Eibrink M; Pieters R; Boot A; Sluimer J; van der Lelij AJ; Neggers S
    Pediatr Blood Cancer; 2012 Oct; 59(4):711-6. PubMed ID: 22162176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
    Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
    Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone mineral density and body composition in adolescents with childhood-onset growth hormone deficiency.
    Boot AM; van der Sluis IM; Krenning EP; de Muinck Keizer-Schrama SM
    Horm Res; 2009; 71(6):364-71. PubMed ID: 19506395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
    Fideleff HL; Boquete HR; Stalldecker G; Giaccio AV; Sobrado PG
    Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Young adult survivors of childhood acute lymphoblastic leukemia: spontaneous GH secretion in relation to CNS radiation.
    Jarfelt M; Bjarnason R; Lannering B
    Pediatr Blood Cancer; 2004 Jun; 42(7):582-8. PubMed ID: 15127412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone loss after childhood acute lymphoblastic leukaemia: an observational study with and without GH therapy.
    Follin C; Link K; Wiebe T; Moëll C; Björk J; Erfurth EM
    Eur J Endocrinol; 2011 May; 164(5):695-703. PubMed ID: 21378089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteopenia, physical activity and health-related quality of life in survivors of brain tumors treated in childhood.
    Odame I; Duckworth J; Talsma D; Beaumont L; Furlong W; Webber C; Barr R
    Pediatr Blood Cancer; 2006 Mar; 46(3):357-62. PubMed ID: 16035080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial.
    Willemsen RH; Arends NJ; Bakker-van Waarde WM; Jansen M; van Mil EG; Mulder J; Odink RJ; Reeser M; Rongen-Westerlaken C; Stokvis-Brantsma WH; Waelkens JJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):485-92. PubMed ID: 17561977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of growth hormone (GH) on bone mineral status and bone turnover markers in patients with isolated GH deficiency and multiple pituitary hormone deficiency.
    Gonc EN; Kandemir N
    Clin Endocrinol (Oxf); 2007 May; 66(5):672-7. PubMed ID: 17381489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term effects of 7-year growth hormone substitution on bone metabolism, bone density, and bone quality in growth hormone-deficient adults].
    Wilhelm B; Kann PH
    Med Klin (Munich); 2004 Oct; 99(10):569-77. PubMed ID: 15490072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine and metabolic disorders in young adult survivors of childhood acute lymphoblastic leukaemia (ALL) or non-Hodgkin lymphoma (NHL).
    Steffens M; Beauloye V; Brichard B; Robert A; Alexopoulou O; Vermylen Ch; Maiter D
    Clin Endocrinol (Oxf); 2008 Nov; 69(5):819-27. PubMed ID: 18429947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.